Detalles de la búsqueda
1.
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Diabetes
; 51(4): 1194-200, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11916944
2.
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation.
J Biol Chem
; 282(13): 9411-9419, 2007 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17255105
3.
Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues.
Mol Pharmacol
; 61(5): 1033-40, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11961121
4.
Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.
Mol Pharmacol
; 64(3): 533-46, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12920188
Resultados
1 -
4
de 4
1
Próxima >
>>